Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and oncology research. NEW YORK, NY, UNITED STATES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results